MM
iota Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Neurological Therapies | Neurological Disorders (e.g., via neuromodulation/BCI) | Pre-clinical |
| Urological Therapies | Urological Disorders | Pre-clinical |
Leadership Team at iota Biosciences
GM
Gil Mandelbaum, PhD
General Manager, Neurological Therapies; Senior Director, Neuromodulation and BCIs
MW
Michael Woods, MD
General Manager, Urological Therapies; Senior Director, Bioelectronic Medicine
LM
Lusin Markaryan
Senior Director of Regulatory Affairs
CC
Carmela Cusumano
Director of Clinical Operations